ZA201408290B - Hydrochloride salt of peptide and its use in combination with other peptides for immunotherapy - Google Patents

Hydrochloride salt of peptide and its use in combination with other peptides for immunotherapy

Info

Publication number
ZA201408290B
ZA201408290B ZA2014/08290A ZA201408290A ZA201408290B ZA 201408290 B ZA201408290 B ZA 201408290B ZA 2014/08290 A ZA2014/08290 A ZA 2014/08290A ZA 201408290 A ZA201408290 A ZA 201408290A ZA 201408290 B ZA201408290 B ZA 201408290B
Authority
ZA
South Africa
Prior art keywords
immunotherapy
peptides
peptide
combination
hydrochloride salt
Prior art date
Application number
ZA2014/08290A
Other languages
English (en)
Inventor
Farkas Imre
Laidler Paul
Original Assignee
Circassia Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Circassia Ltd filed Critical Circassia Ltd
Publication of ZA201408290B publication Critical patent/ZA201408290B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/35Allergens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/57Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/577Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 tolerising response

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
ZA2014/08290A 2012-05-11 2014-11-12 Hydrochloride salt of peptide and its use in combination with other peptides for immunotherapy ZA201408290B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB201208293A GB201208293D0 (en) 2012-05-11 2012-05-11 Hydrochlorice salt of peptide
PCT/GB2013/051201 WO2013167897A1 (en) 2012-05-11 2013-05-09 Hydrochloride salt of peptide and its use in combination with other peptides for immunotherapy

Publications (1)

Publication Number Publication Date
ZA201408290B true ZA201408290B (en) 2016-01-27

Family

ID=46396890

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2014/08290A ZA201408290B (en) 2012-05-11 2014-11-12 Hydrochloride salt of peptide and its use in combination with other peptides for immunotherapy

Country Status (17)

Country Link
US (1) US9657061B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP2847209B8 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JP5982562B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR20150014955A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN104428311B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU2013257784A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BR (1) BR112014028130A2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2873120A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EA (1) EA201492068A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (2) GB201208293D0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HK (1) HK1201850A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL235388A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN (1) IN2014DN09367A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MX2014013394A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SG (1) SG11201407446TA (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO2013167897A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA201408290B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201406569D0 (en) 2014-04-11 2014-05-28 Stabilitech Ltd Vaccine compositions
GB201501017D0 (en) * 2014-12-23 2015-03-04 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers
PT3545965T (pt) 2014-12-23 2021-09-20 Immatics Biotechnologies Gmbh Novos péptidos e combinações de péptidos para uso na imunoterapia contra o carcinoma hepatocelular (chc) e outros cancros
LT3388075T (lt) 2015-03-27 2023-11-10 Immatics Biotechnologies Gmbh Nauji peptidai ir peptidų deriniai, skirti naudoti imunoterapijai prieš įvairius navikus (seq id 25 - mrax5-003)
GB201505305D0 (en) 2015-03-27 2015-05-13 Immatics Biotechnologies Gmbh Novel Peptides and combination of peptides for use in immunotherapy against various tumors
GB2562241B (en) 2017-05-08 2022-04-06 Stabilitech Biopharma Ltd Vaccine compositions
TWI792442B (zh) * 2021-07-23 2023-02-11 建誼生技股份有限公司 依特卡肽鹽酸鹽之製造方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2316632T3 (es) * 2001-12-05 2009-04-16 Circassia Limited Metodos y sistemas inmunoterapeuticos.
SI1984009T1 (sl) 2006-01-18 2013-02-28 Qps, Llc Farmacevtski sestavki z izboljĺ ano stabilnostjo
GB0710529D0 (en) * 2007-06-01 2007-07-11 Circassia Ltd Vaccine
CA2696563A1 (en) * 2007-08-15 2009-02-19 Circassia Limited Peptides for vaccine
GB2455108A (en) * 2007-11-28 2009-06-03 Circassia Ltd T-Cell dependent method for detecting non-allergic or intrinsic disorders
GB0821806D0 (en) * 2008-11-28 2009-01-07 Circassia Ltd Compositions with reduced dimer formation
ES2617921T3 (es) * 2010-03-31 2017-06-20 Stabilitech Ltd. Excipientes para estabilizar partículas virales

Also Published As

Publication number Publication date
SG11201407446TA (en) 2015-03-30
US20150110820A1 (en) 2015-04-23
EP2847209A1 (en) 2015-03-18
IN2014DN09367A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2015-07-17
KR20150014955A (ko) 2015-02-09
US9657061B2 (en) 2017-05-23
HK1201850A1 (en) 2015-09-11
CA2873120A1 (en) 2013-11-14
JP5982562B2 (ja) 2016-08-31
AU2013257784A1 (en) 2014-11-20
CN104428311A (zh) 2015-03-18
EP2847209B8 (en) 2020-10-07
EP2847209B1 (en) 2020-08-05
EA201492068A1 (ru) 2015-03-31
JP2015517484A (ja) 2015-06-22
GB201421491D0 (en) 2015-01-14
GB201208293D0 (en) 2012-06-20
GB2517354A (en) 2015-02-18
MX2014013394A (es) 2015-02-04
BR112014028130A2 (pt) 2017-08-15
CN104428311B (zh) 2019-11-01
WO2013167897A1 (en) 2013-11-14
IL235388A (en) 2016-06-30

Similar Documents

Publication Publication Date Title
IL260045B (en) Polypeptide structures and their uses
IL230918A0 (en) Modified proteins and peptides
ZA201308251B (en) Amino acid sequence presenting fusion polypeptide and its use
ZA201404962B (en) Modified mini-hepcidin peptides and methods of using thereof
EP2928562A4 (en) PEPTIDE THERAPEUTIC PRODUCTS AND METHODS OF USE
IL279676A (en) Recombinant proteins and therapeutic uses
EP2788013A4 (en) AROMATIC-CATIONIC PEPTIDES AND USES THEREOF
EP2720704A4 (en) AROMATIC-CATIONIC PEPTIDES AND USES THEREOF
SG184289A1 (en) Novel peptides and methods for their preparation and use
EP2874642A4 (en) Anti-inflammatory proteins and peptides, and methods for their preparation and use
HUE044549T2 (hu) Peptidek és azok felhasználása
ZA201408290B (en) Hydrochloride salt of peptide and its use in combination with other peptides for immunotherapy
ZA201400562B (en) Axmi205 variant proteins and methods for their use
SG11201500111VA (en) Peptides and uses thereof
IL233481A0 (en) Peptides and methods of using them
IL237135B (en) Peptide library and their uses
PL2668205T3 (pl) Peptydy pochodzące z ludzkiej laktoferyny i ich zastosowanie
EP2825548A4 (en) MODIFIED KISSPEPTIN PEPTIDES AND USES THEREOF
EP2762149A4 (en) PEPTIDE DERIVED FROM ERYTHROPOIETIN AND USE THEREOF
EP2907870A4 (en) REPROGRAMMING PEPTIDE AND USE THEREOF
EP2680879A4 (en) PEPTID LINKERS FOR POLYPEPTIDE COMPOSITIONS AND APPLICATION METHOD THEREFOR
EP2836227A4 (en) AROMATIC-CATIONIC PEPTIDES AND USES THEREOF
EP2771689A4 (en) PEPTIDES USP2A AND ANTIBODIES
GB201121236D0 (en) Proteins and peptides
GB201121233D0 (en) Modified proteins and peptides